All News
Six Things Rheumatologists Need to Know About COVID-19
From flu shots and face masks to vaccines and searching for the immunological endotype, here are six things rheumatologists need to know about COVID-19.
Read Article
Should we in rheumatology be the ones leading the trials using our drugs with checkpoint inhibitors?
Can we learn lessons about collaborative work from @rheum_covid?
Provoking questions for the new challenges in treatment of irAEs! https://t.co/chl8TeOoMy
David Liew drdavidliew ( View Tweet)
Great talk by @rheumcat @rheum_covid on COVID-19 impact on rheumatology. Talk to pts re: what to do with rheum rx... they haven't read guidelines and may make their own changes! Prepare them for exposure/ifn! #ACR20 @Rheumnow 2F042 https://t.co/HkxbkYjEm3
Eric Dein ejdein1 ( View Tweet)
Another study on rheum pt outcomes w/#COVID19: similar outcomes as nonrheum pts. MGH/JHU/Brigham 143 rheum vs 688 nonrheum. No⬆️risk in rheums after adjusting for race/smoking/comorbidities for: hospitalizations, mech ventil'n 3. ICU 4. death #ACR20 Abstr#L01 @RheumNow https://t.co/362UZUe5dg
k dao KDAO2011 ( View Tweet)
Dr. Phillips touches on a few things to consider how teleheath has changed the delivery of care due to COVID-19. Planning your post-pandemic business strategy, due demand for our specialty, is important. #ACR20 @RheumNow https://t.co/A2dsVy1KSg
Dr. Rachel Tate uptoTate ( View Tweet)
Highlighting results from @rheum_covid at #ACR20
Race/ethnicity Associated with Poor Outcomes in #RheumaticDisease Patients with #COVID19 by @MilenaGianfran et al
Abstract #0006👉https://t.co/13jsl8BjcH
Full paper👉https://t.co/Qeo0dOoIOQ
@RheumNow
https://t.co/U9cgaYYaOj
Links:
Mrinalini Dey DrMiniDey ( View Tweet)
#ACR20 keynote Infectious disease Dr Eric Rubin @NEJM EIC answers questions about medications, immunity and vaccines in #COVID19. Many post covid inflammatory symptoms but not sure if its because of background autoimmunity. Need more data. More to come in a few months @RheumNow
Bella Mehta bella_mehta ( View Tweet)
Eric Rubin, MD, editor-in-chief @NEJM #ACR20 discusses how New Zealand can have large rugby matches by intervening before infection occurs. #LTF, @RheumNow.
Eric Dein ejdein1 ( View Tweet)
Reminder of the glucocorticoids (GC) paradigm: don’t use them early during viral replication as morbidity and mortality (M&M) can increase with early use! But GCs CAN prevent the late complications that cause M&M when used at the appropriate time point. #ACR20 @RheumNow https://t.co/l2e0J1nANd
Meral K. El Ramahi, MD MeralElRamahiMD ( View Tweet)
The GRA now have >17,000 pts registered! Watch the video link @rheumnow or YouTube: https://t.co/tdp5q7tAPK
Please visit the GRA booth @rheum_cat @JYazdanyMD @philipcrobinson @rheum_covid #ACR20 https://t.co/UObvGO3n9Q
Links:
k dao KDAO2011 ( View Tweet)
Where one lives matters! Especially during the #COVID19 "flares" - Geographical variations in risk perception and medication management by rheumatologists vary by #COVID19 case burden in the community. Check our abst#0005 #ACR20 @RheumNow
Bella Mehta bella_mehta ( View Tweet)
How would you change csDMARDS and bDMARDS a few days before vaccination - if/when #COVID19 KILLED vaccine comes in (Assuming live vaccine would need strict medication management.) #ACR20 @RheumNow
Bella Mehta bella_mehta ( View Tweet)
APS induced by CoViD-19: plenary session 1- another reason we need to break down the silos and involve rheumatologist more! Should we be using anticoagulation in these patients? #ACR20 @RheumNow @OSUWexMed
alexa meara lexmeara ( View Tweet)
Data from @rheum_covid global registry: "race & ethnicity associated with poor health outcomes in #rheumaticdisease patients with #COVID19 in US. @MilenaGianfran
et al.
Important work highlighting health disparities in COVID-19.
Abs#0006 #ACR20 @RheumNow https://t.co/4e3gAUJ4q1
Mrinalini Dey DrMiniDey ( View Tweet)
Impact of #COVID19 on #rheum patients in Arab region @Nellziade
-2163 pts
-Negative effects on continuity of care, persistence on chronic meds & #mentalhealth
-Recommends better communication & drug availability for pt benefit
Abs#0004 #ACR20 @RheumNow https://t.co/EGmBmcleAr
Mrinalini Dey DrMiniDey ( View Tweet)
Abs#0012 at #ACR20 shows #rheumatology patients in the US had significant changes to healthcare and access to meds during #COVID19.
https://t.co/2x7j47WiZL
For patients & clinicians: what do you consider to be the most important impact on rheumatology due to COVID-19?
@RheumNow
Mrinalini Dey DrMiniDey ( View Tweet)
Huge congrats @kmdsilvaMD on your @RheumResearch Scientist Development Award- "Respiratory Complications of #COVID19 in Rheumatic Diseases." Be sure to also join Kristin tomorrow as she presents at the #ACR20 plenary! @MGH_ClinEpi https://t.co/LamvuWTMIW
MGH Rheumatology MGHrheumatology ( View Tweet)
Delighted to be reporting for @RheumNow at #ACR20!
Here, I review the last year in #infection in #rheumaticdiseases (it’s been a busy one!) and highlight just a few of the abstracts on infections (incl #COVID19), #vaccination and #immunogenicity. Enjoy!
https://t.co/x1pzyOICAF
Mrinalini Dey DrMiniDey ( View Tweet)
COVID-19 use of dexamethasone- why does it work? When to use it ?Is it hyperferrintemic sepsis? Vs early MAS vs? More data needed but this why rheumatologists are needed!!! @RheumNow #ACR20 thank you dr. Rubin! https://t.co/MvQJGqsqu2
alexa meara lexmeara ( View Tweet)
What is your top concern about the SARS-Co-V2 vaccine for rheum patients? @RheumNow #ACR20
k dao KDAO2011 ( View Tweet)
